Darren M. Smith MD. FACS
A topless person covering their breasts with both hands against a plain background.
Super DoctorsAmerican Board of Plastic SurgeryThe Aesthetic Society

Motiva Breast Augmentation NYC

Contact Us
4.9 from 150+ reviews

Before & After: Breast Augmentation NYC

1/3

Gallery photo 1
Gallery photo 2
Gallery photo 3
Gallery photo 4
Gallery photo 5
Explore our gallery of real patient results. These before-and-after photos reflect the life-changing outcomes of plastic surgery performed by Dr. Smith.
Visit Gallery

Being a Nurse I look at medical and surgical procedures slightly differently. So I guess you can say I’m more critical than most. But I only have the upmost positive take away from my experience with Dr Darren Smith and all of his staff. Everything from beginning (consultation) to end (post op care) was exceptional. He listened to my concerns and guided me to a natural enhanced outcome …

S G

What Is a Motiva Breast Augmentation?


A Motiva breast augmentation is a primary or revision breast enlargement performed with implants manufactured by Establishment Labs (NASDAQ: ESTA). On September 26, 2024, the U.S. Food and Drug Administration granted Premarket Approval (PMA P230005) to the Motiva SmoothSilk® Round and Motiva SmoothSilk® Ergonomix® silicone gel-filled breast implants for breast augmentation in women aged 22 years and older — covering both primary augmentation and revision-augmentation. This was the first new breast implant PMA issued by the FDA since 2013.
Motiva implants have been used clinically in more than 80 countries since 2010, with millions of devices implanted internationally. Their U.S. arrival represents the first material change in the available implant landscape in over a decade — a landscape that, until 2024, was dominated by Allergan, Mentor (Johnson & Johnson), and Sientra silicone and saline devices.
What distinguishes the Motiva system is a combination of four engineered features: the SmoothSilk® / SilkSurface® nanotextured shell, ProgressiveGel® silicone gel formulations, the TrueMonobloc® integrated shell-patch-gel structure, and the optional Q Inside® Safety Technology RFID micro-transponder for lifelong device traceability.

Why Dr. Smith for Motiva Breast Augmentation in NYC

Selection of a surgeon for Motiva implants in Manhattan should be evidence-based. The following credentials are directly relevant to this procedure.
  • Author, textbook chapter on Preservé breast augmentation with Motiva implants. Dr. Smith authored a published textbook chapter on the Preservé technique using Motiva implants — the surgical methodology that pairs Motiva’s flexible-shell devices with tissue-conserving instruments (Channel Separator and inflatable sizer/balloon). Few surgeons in the United States have contributed peer-reviewed didactic material on this specific procedure.
  • Dual fellowship training. Dr. Smith completed a craniofacial surgery fellowship at The Hospital for Sick Children in Toronto and an aesthetic surgery fellowship at Manhattan Eye, Ear and Throat Hospital (MEETH) — historically one of the most competitive aesthetic surgery fellowships in the country. The combination of reconstructive precision and aesthetic refinement is uncommon.
  • President, New York Regional Society of Plastic Surgeons (NYRSPS). Founded in 1960, NYRSPS is the regional academic body representing plastic surgeons across the New York area. Dr. Smith currently serves as its President.
  • More than 200 peer-reviewed publications. Dr. Smith’s academic body of work spans aesthetic, craniofacial, and reconstructive surgery and includes a U.S. patent.
  • Board certification. Dr. Smith is certified by the American Board of Plastic Surgery and is a Fellow of the American College of Surgeons (FACS).
  • Solo, cash-pay Manhattan practice. Every procedure is performed personally by Dr. Smith. The practice operates from a private suite in the Ritz Tower at 111 East 57th Street.

The Motiva Implant System: What Manhattan Patients Should Understand

SmoothSilk® / SilkSurface® — the shell

Motiva implants use a proprietary nanotextured surface created by a 3D inversion manufacturing process. The surface is engineered to be smoother than legacy "textured" devices (such as the Allergan Biocell line withdrawn from the market in 2019 over BIA-ALCL concerns) yet less slick than fully smooth shells. The intent is to reduce mechanical inflammation, biofilm formation, and capsular contracture without the high-roughness profile linked to BIA-ALCL.
In FDA peer-reviewed literature, no cases of BIA-ALCL or BIA-SCC were reported in either the primary or revision augmentation cohorts of the Motiva U.S. IDE study at three-year follow-up (Glicksman C, Wolfe A, McGuire P. Aesthetic Surgery Journal, 2024).

ProgressiveGel® — the filler

Motiva implants are filled with sixth-generation cohesive silicone gels:
  • ProgressiveGel Ultima® is used in Motiva Ergonomix® and Ergonomix2® implants. It is the softest of the Motiva fills and behaves dynamically — the implant takes a rounder appearance when the patient is supine and assumes a teardrop profile when upright.
  • ProgressiveGel PLUS® is used in Motiva Round and Anatomical TrueFixation® implants. It is firmer and produces more upper-pole projection.

TrueMonobloc® / TrueMonobloc+®

The shell, patch, and gel are integrated into a single cohesive unit, allowing the implant to be compressed during insertion through a small incision without compromising structural integrity. This matters for the Preservé technique, where incision length is intentionally minimized.

BluSeal® / BluSeal+®

A blue-tinted barrier layer in the shell allows the surgeon to visually confirm shell integrity prior to insertion.

Q Inside® Safety Technology (Qid®)

Motiva is the only breast implant system with an integrated RFID micro-transponder. Q Inside is a passive (battery-free), MR-conditional chip cleared by the FDA in 2004 for use in humans. A handheld reader retrieves a 15-digit electronic serial number that returns manufacturing date, lot, size, projection, and surface — without imaging or surgery. Patients never need to locate a paper warranty card again.
Contact Us

The Preservé Technique with Motiva: Why It Matters

What is Preservé?

Preservé is a tissue-preservation breast augmentation technique developed in collaboration with Motiva and originally pioneered by Dr. Manuel Chacón at the Centro Europeo de Cirugía in Costa Rica. The Preservé system replaces the more traumatic dissection of conventional augmentation with two purpose-built instruments: a Channel Separator that gently spreads tissue planes, and an inflatable saline sizer/balloon that expands the pocket atraumatically.
The technique is paired with the flexible Motiva Ergonomix implant because the implant’s TrueMonobloc design tolerates compression through a small inframammary incision.

What Preservé conserves

  • The pectoralis major muscle. Preservé is typically performed in the subglandular or subfascial (over-the-muscle) plane, avoiding the muscle release required for traditional submuscular (dual-plane) augmentation. This eliminates animation deformity.
  • Cooper’s ligaments and the circummammary support structures.
  • Nipple-areolar sensation pathways.
  • Native breast tissue volume.

Published clinical signal

In Establishment Labs’ Preservé clinical assessment, the technique demonstrated 0% inferior implant malposition at three years in appropriately selected patients. Patients also report a quicker functional recovery and reduced postoperative tightness, although these outcomes are surgeon- and patient-dependent.

Dr. Smith’s textbook chapter

Dr. Smith is the author of a textbook chapter on the Preservé approach with Motiva implants. This work codifies indications, instrument handling, pocket creation, implant insertion, and revision considerations. Patients should understand that the body of operative knowledge their surgeon brings into the room is itself part of the standard of care.

Who is a Preservé candidate?

Preservé is best suited to patients who:
  • Are seeking a primary augmentation in the range of one to two cup sizes (Motiva Ergonomix devices accommodate up to approximately 315 cc through the Preservé balloon system).
  • Have adequate native soft-tissue coverage.
  • Prefer a softer, more natural look without dramatic upper-pole projection.
  • Are physically active and want to avoid pectoralis disruption.
  • Are non-smokers in stable health.
Patients seeking larger volumes, those with very thin tissue, or revision cases with significant capsular pathology may be better served by a different placement plan, which Dr. Smith will outline at consultation.

Safety Profile: What the Data Show

Capsular contracture

In the FDA IDE study (Glicksman et al., Aesthetic Surgery Journal, 2024), the three-year capsular contracture rate in the primary augmentation cohort was 0.5%. A 2023 meta-analysis of 4,784 patients implanted with Motiva SmoothSilk devices reported an overall complication rate of 5.2% across short- and medium-term follow-up.

Rupture

The three-year confirmed-or-suspected rupture rate in the FDA IDE primary augmentation cohort was 0.6%.

Reoperation

The three-year reoperation rate in the primary augmentation cohort was 6.1%, with most reoperations driven by subjective indications such as size change rather than device failure — a meaningful shift from prior-generation implant data.

BIA-ALCL and BIA-SCC

No cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) or breast implant-associated squamous cell carcinoma (BIA-SCC) were reported in either Motiva FDA IDE augmentation cohort at three years. Dr. Smith reviews these data in context: BIA-ALCL has historically been associated with macrotextured implants (most prominently the recalled Allergan Biocell line). The FDA continues to monitor breast implant safety and has required Motiva to conduct 10-year post-approval surveillance on the IDE cohort plus a 2,400-patient prospective post-approval study.

Patient satisfaction

Three-year patient satisfaction in the FDA IDE primary augmentation cohort was 97.1%; physician satisfaction was 99.0%.

Caveats Dr. Smith discusses with every patient

  • Several Motiva clinical studies have been authored by surgeons with disclosed financial relationships to Establishment Labs. Dr. Smith reviews this transparency directly.
  • Long-term (10+ year) U.S. data are still maturing because U.S. PMA approval was granted in 2024.
  • All breast implants — Motiva, Mentor, and Sientra — require periodic imaging surveillance per FDA guidance.
Contact Us

Candidacy: Is Motiva Right for You?

You may be a candidate for Motiva breast augmentation in NYC if you:
  • Are at least 22 years of age (FDA indication for silicone augmentation).
  • Have completed pregnancy and breastfeeding, or are not currently planning pregnancy in the immediate term.
  • Are at a stable weight (post–GLP-1 weight stabilization is a frequent referral pattern in Dr. Smith’s practice).
  • Are seeking a one- to two-cup-size enhancement (especially for Preservé) or a fuller upper-pole result (Motiva Round).
  • Are a non-smoker, or are willing to abstain from nicotine for the perioperative window.
  • Have no active infection, untreated breast malignancy, or contraindicated medical condition.
  • Understand that implants are not lifetime devices and may require revision or replacement.
Patients seeking revision augmentation — including explant of older Allergan, Mentor, or Sientra devices, capsulectomy, or implant exchange to Motiva — represent a meaningful portion of Dr. Smith’s consultative volume.

The Patient Journey at the Ritz Tower

Step 1 — Consultation

Consultations are conducted in the private suite at 111 East 57th Street. Dr. Smith personally performs the history, examination, and tissue assessment, including chest-wall measurements, soft-tissue thickness, base width, and asymmetry mapping. 3D imaging is offered for size and shape simulation. The conversation covers Motiva implant selection (Round vs. Ergonomix, projection, volume), incision plan (typically inframammary fold), placement plane (subglandular/subfascial for Preservé candidates; submuscular when indicated), and whether Preservé is appropriate.

Step 2 — Pre-operative planning

Pre-operative laboratory workup, mammography or breast imaging when indicated, medical clearance, and review of medications and supplements (anticoagulants, GLP-1 agonists, hormonal therapy) are coordinated by the practice.

Step 3 — Surgery

Breast augmentation is performed in an accredited operating facility with board-certified anesthesia. Dr. Smith uses a Keller-style funnel for no-touch implant insertion, antibiotic-impregnated pocket irrigation per the 14-Point Plan, and meticulous hemostasis. Preservé cases use the Motiva Channel Separator and inflatable balloon. Most primary augmentations require 60–90 minutes of operative time.

Step 4 — Recovery

Patients are discharged the same day. Most return to desk work and light activity within 5–7 days. Cardiovascular exercise resumes at 3 weeks; chest and upper-body strength training at 6 weeks. Preservé patients frequently report a faster functional recovery than traditional submuscular patients because the pectoralis is left intact. Final shape settles over 3–6 months. Implant registration with Motiva (via the MotivaImagine app) occurs within 90 days for full warranty coverage.

Step 5 — Long-term follow-up

The FDA recommends MRI or high-resolution ultrasound screening for silent rupture beginning 5–6 years after silicone augmentation and every 2–3 years thereafter. Dr. Smith manages this surveillance schedule in coordination with the patient’s primary care or breast imaging team.

Cost: A Cash-Pay Manhattan Practice

Dr. Smith operates a cash-pay aesthetic practice. Total fees for Motiva breast augmentation in NYC reflect surgeon expertise and credentials, facility and anesthesia fees, the Motiva implants themselves (which are positioned at the higher end of the implant market because of the Q Inside RFID, lifetime rupture warranty, and 10-year capsular contracture replacement policy), pre- and post-operative care, and any combined procedures (e.g., breast lift, mommy makeover, GLP-1 body contouring).
Specific quotes are provided after in-person consultation because volume, technique (Preservé vs. traditional), placement plane, and combined procedures all influence the final number. The practice does not advertise generic price points because they do not reflect the individualized surgical plan.

Combined and Adjacent Procedures

Patients frequently combine Motiva breast augmentation with:
  • Mommy makeover (Motiva augmentation + abdominoplasty + liposuction) 
  • Breast lift (mastopexy-augmentation) for patients with grade 2–3 ptosis.
  • GLP-1 body contouring / Mounjaro Makeover — for patients who have stabilized after semaglutide or tirzepatide-related weight loss and are now addressing residual breast deflation.
  • Breast revision — explant, capsulectomy, and exchange to Motiva from a prior device.
Contact Us
VogueAllureElleByrdieCBSRefinery29The New York Times

Real Patient Testimonials

“I Should Never Consider Another Plastic Surgeon!”

My experience with Dr. Darren Smith and his staff made it obvious that I should never consider another plastic surgeon! I had several consultations with other cosmetic surgeons for a breast lift procedure before making the indisputable choice to go with Dr. Darren Smith.

S K

Contact Us

Motiva Breast Augmentation NYC: Frequently Asked Questions

Motiva Breast Augmentation NYC in the Heart of New York City

Dr. Smith’s practice sits in Manhattan’s Upper East Side, steps from Central Park and at the center of New York City’s most established medical corridor. The office welcomes patients from across the five boroughs, the tri-state area, and well beyond.

Choosing where you have surgery matters as much as choosing who performs it. New Yorkers come to Dr. Smith because his work reflects the city itself: refined, exacting, and never one-size-fits-all. Whether you’re a lifelong New Yorker or traveling in for a consultation, you’ll find a practice that treats every patient with precision and discretion that have made Manhattan a destination for plastic surgery patients from around the world.

Belvedere Castle in Central Park, New York City — steps from Dr. Smith's Manhattan practice

Schedule a Motiva Breast Augmentation NYC Consultation with Dr. Darren Smith

Call Today (212) 633-0627

“Within the first couple of minutes of meeting him, I knew he was the doctor for me.”

N F

New York, NY

Google
4.9

By submitting this you agree to be contacted by Dr. Darren Smith via text, call or email. Standard rates may apply. For more details, read our Privacy Policy.